Video Series
Expert retina specialists discuss the efficacy and safety data of the ranibizumab biosimilar, SB11, and explore the practical implications of biosimilars in the broader real-world context.
Advertisement
Advertisement
Trending on Modern Retina
1
Current and Emerging Treatments for Geographic Atrophy and When to Initiate Therapy
2
Dompé's NAION program selected for FDA Commissioner’s National Priority Voucher Program
3
FDA approves Glaukos’ Epioxa incision-free keratoconus therapy
4
